ClinicalTrials.Veeva

Menu

Malnutrition in Older Adults: An Intervention Based on Medication Review and Individual Nutritional Plan

U

University of Oslo

Status

Unknown

Conditions

Polypharmacy
Malnutrition
Aged

Treatments

Dietary Supplement: Individualized plan for improvement of nutrition
Drug: Systematic drug review

Study type

Interventional

Funder types

Other

Identifiers

NCT04228900
2017/12883-2

Details and patient eligibility

About

The project "Nutrition and Medication management in home-dwelling older adults" consist of two separate studies witch are described in the same study protocol. This is the second study in this Project. The first study (cross sectional) is described separately; Identification: 2017/12883-1

Undernutrition is common in older adults. The causes are many and include drug therapy. Drug side effects, as loss of appetite, nausea, or dry mouth, may contribute to malnutrition, impaired health and loss of function.

In patients with malnutrition or at risk for malnutrition we will evaluate an intervention consisting of:

  • an "individual nutritional plan" with different measures aiming at improving nutritional status.
  • a systematic drug review.

Full description

The participants will be recruited by the home nursing services or by a nurse at a short-time ward in the nursing home.

The composite intervention consists has two components (A and B):

Component A: Clinical assessment and critical medication review

Drawing on information from the medical history, clinical finding according to examination made by the principal investigator (trained physician), information from the General Practitioner (GP) and the findings from blood tests, we will make a systematic and critical medication review. This systematic review has the following considerations:

  • Are drug-drug unintended interactions likely to occur? Interaction analysis supported by https:// www.interaksjoner.no
  • Are there use of potentially inappropriate medication? Assessed based on the Norwegian General Practice Nursing -Home criteria.
  • Could nutritional related problems like loss of appetite, dry mouth and nausea, be attribute to adverse drug effects? Assessed by the list we made of drugs who often contributes to these side effects according to The Norwegian Pharmaceutical Product Compendium.

Component B: Nutritional intervention- individual nutrition plan. Drawing on the principles for good nutritional practice, and National guidelines, this component include the following considerations:

  • Nutritional status by use of Mini Nutritional Assessment short form (MNA-SF), and further in- depth nutrition assessment if MNA-SF is in range 0-11.
  • Assessment of the nutritional needs.
  • Assess food and drink intake with a 3- day dietary record to the estimated nutritional needs.
  • In collaboration with the home nurse, the participant and if possible/ necessary a next to kin, focusing on individual problems and develop an individual nutritional plan.

The project is about a controlled implementation of measures recommended in current national guidelines. We will follow a principle known as the "Nutritional Stairs", and choose interventions in the nutritional plan as close to "normal" food as possible. This means that the individual nutritional plan takes into account:

  • Physical and mental disorders are diagnosed and optimal treated. (Oral health care included)
  • Intervention to optimize the meal environment and meal itself, e.g., enough light in the room, specific tools to make eating possible if necessary, company
  • The frequency of meals, length of night fasting, special diets as energy- and nutrient dens diets, consistency customized diet (liquid or solid food)
  • Enriched food and in between meals/snacks
  • Nutritional supplements

The intervention last six months, and participants in the intervention group will receive four visits at home; baseline and after 4, 12 and 24 weeks. At baseline and at week 24, the principal investigator (trained physician) and the nurse will visit the participants. At week 4 and 12, only the nurse will visit them. The control group, are visited by a nurse twice: at baseline and after 24 weeks, and are follow-up by the home nurse service and their GP "as usual".

Drop- out during the study period and reasons for "loss to follow-up (LTFU)" will be registered; e.g., moved from the municipality, acute illness that make further participation difficult, admission to long time ward in nursing home, or any other reason to withdraw participation. In the intervention group, we will on behalf of and subject to the participant's consent, make an appointment for consultation by the GP, if the clinical assessment suggests undetected diseases or diseases not optimal treated. If oral health problems are encountered, we will recommend a consultation by a dentist.

Enrollment

50 estimated patients

Sex

All

Ages

70+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 70 year or more
  • Receiving home nurse care each second week or more often
  • Mini Nutritional Assessment short form (MNA-SF): 0-11 point (malnourished or at risk for malnutrition)

Exclusion criteria

  • Life expectance less than 6 month
  • Serious cognitive impairment
  • In need of enteral-/ parenteral nutrition
  • Not able to stand up for weight measure
  • The home care service are not responsible for medication delivery.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Intervention group
Experimental group
Description:
Drug review and tailored nutritional supply.
Treatment:
Dietary Supplement: Individualized plan for improvement of nutrition
Drug: Systematic drug review
Control group
No Intervention group
Description:
Follow-up by home nurse service and family physician "as usual".

Trial documents
5

Trial contacts and locations

1

Loading...

Central trial contact

Straand Jørund, Professor; Mari Fiske, phd

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems